News

Emmes is excited to share the significant progress being made in clinical studies we undertake for clients and to give you a look inside some of our own news.

Press Releases

01/04/2023
Emmes
Matt Honan Joins Emmes as Vice President and Head of Corporate Development
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Matt Honan has joined the company as vice president and global head of corporate development.
12/15/2022
Emmes
Wendy Buckland to Join Emmes as Chief Operating Officer
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Wendy Buckland will join the company as its chief operating officer, leading global operations.
12/14/2022
Emmes
Emmes Hires Ching Tian in New Leadership Role to Accelerate Innovation
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Ching Tian has joined the company as chief innovation officer.
12/08/2022
Emmes
Emmes Launches Cell and Gene Therapy Center
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.
10/26/2022
Emmes
Emmes rapidly expands in India – driven by deep vaccines and infectious diseases expertise and enhanced study startup capabilities
Emmes – a global, full-service Contract Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation – announces it has rapidly expanded its capabilities in India during the last two years.
10/12/2022
Emmes
Emmes Leader Speaks on the Evolving Role of Patient Advocacy in Clinical Research
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that Christine McSherry is speaking at today’s Outsourcing in Clinical Trials conference in Boston, Massachusetts.
06/21/2022
Emmes
New Mountain Capital Announces Growth Partnership with Emmes
Partnership to Support Emmes’ Next Phase of Tech-Enabled Growth
06/16/2022
Emmes
Emmes Supports Groundbreaking Anal Cancer Study Sponsored by the National Cancer Institute
Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that a team of its researchers contributed to a successful AIDS Malignancy Consortium (AMC) study.
05/16/2022
Emmes
Emmes Supports Landmark mRNA COVID-19 Vaccine Trial in Sub-Saharan Africa
Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that it is providing data, statistical analysis, and project management support for new research that will test the Moderna mRNA vaccine at more than 50 sites in South and East Africa.
05/11/2022
Emmes
Emmes launches Advantage eClinical as a standalone cloud native clinical technology platform
The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is supported by Emmes specialist data management teams.
04/27/2022
Emmes
Emmes and Casimir Announce Research About a Novel, Home-Based Assessment for Duchenne Muscular Dystrophy
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Casimir’s research on the development of the Duchenne Video Assessment (DVA) scorecards was published in PLOS ONE. Emmes acquired Casimir in March 2022, and the group is now part of Emmes’ Rare Disease Center, Orphan Reach™.
03/10/2022
Emmes
Emmes Acquires Casimir, Its Fourth Major Acquisition
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that it has acquired Casimir, a U.S.-based CRO.